CDH-Backed Drug Developer Innorna Is Said to Plan Hong Kong IPO

Innorna Co., a Chinese developer of messenger RNA drugs backed by buyout firm CDH Investments, is planning an initial public offering in Hong Kong, according to people familiar with the matter....

Redirecting to full article...